understand the details required for
conducting successful clinical studies,
and we bring that into our develop-
ment process. We provide the com-
plete topical development program.”
“We look at the broad picture,”
says Dow. “We want to make a prod-
uct that patients are going to like
and are going to use.” Having built
a solid foundation on which to grow
and establishing themselves as a
premier supplier of topical product
development services, DDL is ex-
cited about the future.
“In the next five years we want to
expand on what we have established already,” says Dow. “In the contract business it’s all about what clients ask you
to do. So we are certainly open to making decisions based on clients’ needs.
“Our core competency is topical
development and that’s not going to
change. The part of our business that
will develop and expand depends on
whether we get into small scale manu-
facturing or more clinical labeling, ana-
lytical services etc. Those decision will
be driven by client needs. We keep our
ear to the ground and try to anticipate
what clients will need.” n
DDL's team offers extensive development experience.
Vcaps® Plus hypromellose capsules for pharmaceutical products
Secondary gelling agents and ionic gel promoters – used by other
HPMC capsules – may slow down release of active ingredients.
Capsugel’s Vcaps® Plus HPMC capsules are made through a proprietary
manufacturing process that eliminates the need for gelling systems.
They disintegrate and release their contents independent of pH and ionic
strength of the test media. Download our free whitepaper to discover
how Vcaps® Plus capsules can optimize performance, improve product
stability, and reduce drug development times.
Achieving new standards in performance takes
years of innovative R&D. This is the result.